Important: Compounded medications discussed on this page are prepared by Rush Pharmacy or Epiq Scripts, state-licensed compounding pharmacies, for an individual patient pursuant to a valid prescription and are not FDA-approved drug products. Submitting an intake or payment through Luvida Health does not guarantee a prescription. An independent licensed provider from LocumTele will review your information and determine whether treatment is clinically appropriate for you. An asynchronous consult or a video consult may be required. Individual experiences and results vary and are never guaranteed.
Prescription Required
Compounded Tirzepatide
A dual GIP and GLP-1 receptor therapy, prescribed only when an independent licensed clinician determines it is clinically appropriate.
Tirzepatide belongs to the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor therapy class, used in medically supervised weight-management and metabolic care for adults who meet specific clinical criteria. Glucose-dependent insulinotropic polypeptide (GIP) works alongside GLP-1 to interact with metabolic signaling pathways. Through Luvida Health, an independent licensed provider may prescribe a compounded formulation when clinically appropriate. When compounded, it is prepared by Rush Pharmacy or Epiq Scripts for an individual patient and is not an FDA-approved drug product.

Who It May Be For
An independent licensed provider may consider compounded tirzepatide for eligible adults based on health history, current medications, and a clinical evaluation.
- Clinical Evaluation: It is not appropriate for everyone, and only an independent licensed provider can determine whether it fits your individual medical situation.
- Adults 18+: Available to eligible adults aged 18 and older in 50 U.S. states.
- No Prescribing Guarantee: Completing an online intake questionnaire does not guarantee a prescription. Declining treatment is a legitimate clinical outcome if your clinician determines GLP-1 therapy is not safe or appropriate for you.
How Treatment Works
- 1. Secure Intake: You complete a confidential medical questionnaire covering your health history, current medications, and goals. It takes minutes, and your information is handled under HIPAA-aware practices.
- 2. Independent Clinician Review: An independent licensed clinician from LocumTele reviews your information. LocumTele will review your information and determine eligibility via an asynchronous consult or a video consult.
- 3. State-Licensed Pharmacy Fulfillment: If your clinician determines compounded tirzepatide is clinically appropriate, they may issue a prescription to Rush Pharmacy or Epiq Scripts, U.S.-based, state-licensed compounding pharmacies. The pharmacy prepares the medication for you as an individual patient and ships it discreetly to your door.
- 4. Provider-Guided Care: Your clinician guides dosing and follow-up from there. Questions about dosing, side effects, or refills go back to your prescribing provider.
Compounding Transparency & Non-Affiliation
- Compounded Formulation Notice: Compounded tirzepatide is prepared by a state-licensed compounding pharmacy for an individual patient pursuant to a valid prescription. It is not an FDA-approved drug product. The FDA has not reviewed compounded tirzepatide for safety, effectiveness, or quality.
- Non-Affiliation Notice: Compounded tirzepatide is not manufactured by, associated with, or endorsed by Eli Lilly and Company. Eli Lilly manufactures commercial FDA-approved tirzepatide products, including Mounjaro and Zepbound. Luvida Health does not provide or market generic versions of branded medications.
Safety Information & Provider Guidance
Tirzepatide is not appropriate for everyone and may cause side effects, some of which can be serious.
- Boxed Warning for Thyroid C-Cell Tumors: In animal studies with rodents, GLP-1 receptor therapies caused thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), a rare type of thyroid cancer. It is unknown whether these medications cause thyroid C-cell tumors, including MTC, in humans.
- Strict Contraindications: Do not use GLP-1 medications if you or any member of your family has a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), a rare genetic syndrome that causes tumors in hormone-producing glands.
- Allergies: Do not use if you have had a serious allergic reaction to tirzepatide or any ingredients in the formulation.
- Pregnancy & Breastfeeding: Do not use GLP-1 medications if you are pregnant, planning to become pregnant, or breastfeeding. Consult your healthcare provider regarding pregnancy and medication use.
- Medical History: Discuss your full medical history with your provider before starting, including any history of pancreatitis, gallbladder problems, kidney issues, severe gastrointestinal conditions, or diabetic retinopathy.
- Side Effects: Common side effects include nausea, diarrhea, vomiting, constipation, stomach discomfort, and fatigue.
- Emergency Notice: This platform is not for medical emergencies. If you experience an emergency, call 911 immediately. If you are in crisis, call or text 988.
Find out whether compounded tirzepatide is clinically appropriate for you.
Complete a secure medical intake and an independent licensed clinician from LocumTele will evaluate your history.
Prescription required. Adults 18+ only. Available in 50 U.S. states. Compounded medications are not FDA-approved. Individual results vary and are never guaranteed. Not for emergencies: Call 911, or call or text 988.